This inventor holds 2 USPTO granted patents. Top assignees: Ucb S.a., Ucb, S.a./n.v.. Active years: 2004-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004-2005
Title: Olivier Dasse: Innovator in Pharmaceutical Compositions
Introduction
Olivier Dasse is a notable inventor based in Marlborough, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on pyrrolidinone derivatives. With a total of 2 patents, Dasse has established himself as a key figure in the development of novel compounds aimed at treating various medical conditions.
Latest Patents
Dasse's latest patents focus on pyrrolidinone derivatives. The present invention provides pharmaceutical compositions and novel compounds useful in the treatment of conditions mediated by CCR2, MCP-1, or the interaction thereof. The compounds of the present invention are pyrrolidinones and pyrrolidine-thiones. This work highlights his commitment to advancing medical science and improving patient outcomes.
Career Highlights
Throughout his career, Olivier Dasse has worked with prominent companies such as UCB, S.A./N.V. and UCB S.A. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research and development.
Collaborations
Some of his notable coworkers include Dong Zou and Janelle Evans. Their collaborative efforts have further enhanced the impact of Dasse's inventions in the pharmaceutical industry.
Conclusion
Olivier Dasse's contributions to pharmaceutical innovations through his patents and collaborations underscore his importance in the field. His work continues to pave the way for advancements in medical treatments and therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile